Anchorage Capital Group, L.L.C. — 13F Holdings & Portfolio
CIK 1300714 · latest 13F-HR filed 2026-08-14
Anchorage Capital Group, L.L.C. manages $450.5M in 13F-reported U.S. long-equity assets across 3 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are EQPT (77.56%), S (18.60%), DNA (3.84%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 0 new positions, exited 0, added to 2, and trimmed 0.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
6TH FLOOR
NEW YORK, NY 10012
$450.5M
Long-equity book
3
Distinct positions
2026-06-30
Filed 2026-08-14
+0 / −0 / ↑2 / ↓0
vs 2026-03-31
| Name | Title / Status | Ownership | Type |
|---|
Top Adds (vs prior quarter)
- SENTINELONE INC$20.2M +31.8%
- GINKGO BIOWORKS HOLDINGS INC$6.6M +61.7%
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-06-30 | 2026-08-14 | $450.5M | 3 | 0000905148-26-003756 |
| 2026-03-31 | 2026-05-15 | $436.3M | 3 | 0000905148-26-002370 |
| 2025-12-31 | 2026-02-17 | $88.6M | 2 | 0000905148-26-000874 |
| 2025-09-30 | 2025-11-14 | $117.4M | 4 | 0000905148-25-004039 |